Frank Hoebers

Citée par

	Toutes	Depuis 2019
Citations	12379	8223
indice h	45	33
indice i10	107	94

1600

800

400

1200

2005200620072008200920102011201220132014201520162017201820192020202120222023202442 55 40 86 99 106 129 156 178 218 378 591 875 1030 1227 1405 1504 1537 1459 1088

Accès public

Tout afficher

60 articles

2 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Philippe LambinProfessor of Precision Medicine, Maastricht University & Scientist ULBAdresse e-mail validée de maastrichtuniversity.nl
Andre DekkerProfessor of Clinical Data Science, MAASTRO Clinic, Maastricht University, GROW, Maastricht UMC+Adresse e-mail validée de maastro.nl
Ralph T.H. LeijenaarPhDAdresse e-mail validée de maastrichtuniversity.nl
Hugo AertsDirector AI in Medicine (AIM) @ Harvard-MGB | Professor @ MaastrichtUAdresse e-mail validée de dfci.harvard.edu
Emmanuel Rios VelazquezBusiness Development Manager - Precision Health & Nutrition @imec - OnePlanet Research CenterAdresse e-mail validée de imec.nl
Wouter van ElmptMaastricht University Medical CentreAdresse e-mail validée de maastro.nl
Michiel W van den BrekelNetherlands Cancer InstituteAdresse e-mail validée de nki.nl
balm ahoogleraar uvaAdresse e-mail validée de nki.nl
Rene MonshouwerRadboudumc, department of RadiotherapyAdresse e-mail validée de radboudumc.nl
Esther TroostResident in Radiation OncologyAdresse e-mail validée de uniklinikum-dresden.de
dhf rietveldAdresse e-mail validée de amsterdamumc.nl
Catharina M.L. ZegersDepartment of Radiation Oncology (MAASTRO), GROW – School for Oncology and Developmental BiologyAdresse e-mail validée de maastro.nl
Chintan ParmarAstraZeneca (past: PathAI, Novartis, Harvard-DFCI-BWH, ISI-Kolkata, DAIICT)Adresse e-mail validée de astrazeneca.com
Patrick GrossmannPh.D. Candidate conducting research at Harvard Medical School, Dana-Farber Cancer Institute, BWHAdresse e-mail validée de jimmy.harvard.edu
Robert GilliesChair of Cancer Physiology, H. Lee Moffitt Cancer CenterAdresse e-mail validée de moffitt.org
John QuackenbushHarvard T.H. Chan School of Public Health, Channing Division of Network Medicine, and Dana-FarberAdresse e-mail validée de hsph.harvard.edu
Sara João CarvalhoBiostatistician @ Health iQAdresse e-mail validée de medschl.cam.ac.uk
Leonard WeeMaastricht UniversityAdresse e-mail validée de maastro.nl
Harry BartelinkprofessorAdresse e-mail validée de nki.nl
Cary OberijeAdresse e-mail validée de maastrichtuniversity.nl

Suivre

Frank Hoebers

Radiation Oncology (MAASTRO); Maastricht University; Brigham and Women's Hospital, Harvard Medical

Adresse e-mail validée de maastro.nl

Head and Neck Cancer Radiotherapy Machine Learning Artificial Intelligence


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach HJWL Aerts, ER Velazquez, RTH Leijenaar, C Parmar, P Grossmann, ... Nature communications 5 (1), 4006, 2014	4976	2014
Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a … B O'Sullivan, SH Huang, J Su, AS Garden, EM Sturgis, K Dahlstrom, ... The Lancet Oncology 17 (4), 440-451, 2016	786	2016
Machine learning algorithms for outcome prediction in (chemo) radiotherapy: An empirical comparison of classifiers TM Deist, FJWM Dankers, G Valdes, R Wijsman, IC Hsu, C Oberije, ... Medical physics 45 (7), 3449-3459, 2018	295	2018
External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinoma RTH Leijenaar, S Carvalho, FJP Hoebers, HJWL Aerts, WJC Van Elmpt, ... Acta oncologica 54 (9), 1423-1429, 2015	237	2015
Rapid Learning health care in oncology’–an approach towards decision support systems enabling customised radiotherapy P Lambin, E Roelofs, B Reymen, ER Velazquez, J Buijsen, CML Zegers, ... Radiotherapy and Oncology 109 (1), 159-164, 2013	222	2013
Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients … G Thomas, S Ali, FJP Hoebers, KM Darcy, WH Rodgers, M Patel, ... Gynecologic oncology 108 (2), 317-325, 2008	214	2008
CD44 expression predicts local recurrence after radiotherapy in larynx cancer MC de Jong, J Pramana, JE van der Wal, M Lacko, CJ Peutz-Kootstra, ... Clinical Cancer Research 16 (21), 5329-5338, 2010	213	2010
Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival MC Van Harten, FJP Hoebers, KW Kross, ED Van Werkhoven, ... Oral oncology 51 (3), 272-278, 2015	203	2015
Data from NSCLC-radiomics H Aerts, ER Velazquez, RT Leijenaar, C Parmar, P Grossmann, ... The cancer imaging archive, 2015	189	2015
Intra‐arterial versus intravenous chemoradiation for advanced head and neck cancer: Results of a randomized phase 3 trial CRN Rasch, M Hauptmann, J Schornagel, O Wijers, J Buter, T Gregor, ... Cancer 116 (9), 2159-2165, 2010	162	2010
Decision support systems for personalized and participative radiation oncology P Lambin, J Zindler, BGL Vanneste, L Van De Voorde, D Eekers, ... Advanced drug delivery reviews 109, 131-153, 2017	158	2017
In vivo imaging of apoptosis by 99mTc-Annexin V scintigraphy: visual analysis in relation to treatment response M Kartachova, RLM Haas, RAV Olmos, FJP Hoebers, N van Zandwijk, ... Radiotherapy and oncology 72 (3), 333-339, 2004	156	2004
Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: a multicenter study RTH Leijenaar, M Bogowicz, A Jochems, FJP Hoebers, FWR Wesseling, ... The British journal of radiology 91 (1086), 20170498, 2018	144	2018
HIF-1α, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors HLK Janssen, KMG Haustermans, D Sprong, G Blommestijn, I Hofland, ... International Journal of Radiation Oncology* Biology* Physics 54 (5), 1537-1549, 2002	140	2002
Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and … J Heukelom, O Hamming, H Bartelink, F Hoebers, J Giralt, T Herlestam, ... BMC cancer 13, 1-8, 2013	139	2013
Tumor volume as prognostic factor in chemoradiation for advanced head and neck cancer JL Knegjens, M Hauptmann, FA Pameijer, AJ Balm, FJ Hoebers, ... Head & neck 33 (3), 375-382, 2011	130	2011
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014; 5: 4006 HJ Aerts, ER Velazquez, RT Leijenaar, C Parmar, P Grossmann, ...	124	2014
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5: 4006 HJ Aerts, ER Velazquez, RT Leijenaar, C Parmar, P Grossmann, ...	109	2014
In Vivo Quantification of Hypoxic and Metabolic Status of NSCLC Tumors Using [¹⁸F]HX4 and [¹⁸F]FDG-PET/CT Imaging CML Zegers, W Van Elmpt, B Reymen, AJG Even, EGC Troost, MC Öllers, ... Clinical Cancer Research 20 (24), 6389-6397, 2014	107	2014
Evaluation of lasersurgery and radiotherapy as treatment modalities in early stage laryngeal carcinoma: tumour outcome and quality of voice AJ Remmelts, FJP Hoebers, WMC Klop, AJM Balm, O Hamming-Vrieze, ... European Archives of Oto-Rhino-Laryngology 270, 2079-2087, 2013	103	2013

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs